Live feed10:30:00·1642dPRReleasevia QuantisnowAgios Presents Mitapivat Data Highlighting Long-term Safety Profile and Durable Improvement in Hemoglobin and Markers of Hemolysis in Non-transfusion-dependent α- and β-Thalassemia at 63rd ASH Annual Meeting and ExpositionByQuantisnow·Wall Street's wire, on your screen.AGIO· Agios Pharmaceuticals Inc.Health Care
